|
Delayed
TEL AVIV STOCK EXCHANGE
05:20:36 2026-10-20 am EDT
|
5-day change | 1st Jan Change | ||
| 1,404.00 ILa | -1.68% |
|
-8.53% | -13.23% |
| Sep. 08 | InterCure Regains Nasdaq Compliance | MT |
| Aug. 24 | InterCure Ltd. announced that it has received ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical Farming
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 54.55M | - | - | - | - | - |
| 119B | |||||
| 98.48B | |||||
| 57.57B | - | ||||
| 28.37B | |||||
| 25.93B |
- Stock Market
- Stocks
- INCR Stock
- Charts InterCure Ltd.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
